Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/bjh.16979 http://scihub22266oqcxt.onion/10.1111/bjh.16979 32593183!7361819!32593183     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Haematol 2020 ; 190 (4): e198-e200 Nephropedia Template TP {{tp|p=32593183|t=2020. Ruxolitinib for tocilizumab-refractory severe COVID-19 infection |pdf=|usr=}}{{32593183}} gab.com Text Ruxolitinib for tocilizumab-refractory severe COVID-19 infection JO: Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32593183 #FOAvip ä Twit Text FOAVip Ruxolitinib for tocilizumab-refractory severe COVID-19 infection ????Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32593183 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32593183 #FOAvip English Wikipedia <ref>{{Cite pmid|32593183}}</ref> Ruxolitinib for tocilizumab-refractory severe COVID-19 infection #MMPMID32593183 Innes AJ; Cook LB; Marks S; Bataillard E; Crossette-Thambiah C; Sivasubramaniam G; Apperley J; Milojkovic D Br J Haematol 2020[Aug]; 190 (4): e198-e200 PMID32593183show ga ä |*COVID-19 Drug Treatment[MESH] |*Hematopoietic Stem Cell Transplantation[MESH] |*SARS-CoV-2[MESH] |Adult[MESH] |Allografts[MESH] |Antibodies, Monoclonal, Humanized/*administration & dosage[MESH] |Blast Crisis/blood/therapy[MESH] |COVID-19/blood[MESH] |Humans[MESH] |Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood/therapy[MESH] |Male[MESH] |Nitriles[MESH] |Pyrazoles/*administration & dosage[MESH] |Pyrimidines[MESH]Ruxolitinib for tocilizumab-refractory severe COVID-19 infection (epmc).pdf DeepDyve Pubget Overpricing